Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

T. Smith · SciRah

Researcher profile · Semantic Scholar

T. Smith

Share profile

T. Smith — researcher profile on SciRah

h-index: 27
Works: 76
Citations: 2,734

Most-cited papers

Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6‐month, randomized, double‐blind, placebo‐controlled, fixed‐dose trial☆
Jon I. Russell, P. Mease, T. Smith, D. Kajdasz +5 more
2008Pain375 citations
Semantic Scholar
Consensus Statement: Cardiovascular Safety Profile of Triptans (5‐HT1B/1D Agonists) in the Acute Treatment of Migraine
D. Dodick, Richard B. Lipton, V. Martin, V. Papademetriou +12 more
2004Headache320 citations
Semantic Scholar
Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
T. Philipp, T. Smith, R. Glazer, M. Wernsing +4 more
2007Clinical Therapeutics265 citations
Semantic Scholar
Sumatriptan and Naproxen Sodium for the Acute Treatment of Migraine
T. Smith, A. Sunshine, Stuart R. Stark, D. Littlefield +2 more
2005Headache154 citations
Semantic Scholar
Duloxetine versus Routine Care in the Long-Term Management of Diabetic Peripheral Neuropathic Pain
J. Raskin, T. Smith, K. Wong, Y. Pritchett +3 more
2006Journal of Palliative Medicine116 citations Open access
Semantic Scholar
Cardiovascular Tolerability and Safety of Triptans: A Review of Clinical Data
D. Dodick, V. Martin, T. Smith, S. Silberstein
2004Headache115 citations
Semantic Scholar
Safety and Efficacy of PNU-142633, a Selective 5-HT1D Agonist, in Patients with Acute Migraine
B. Gomez-Mancilla, N. Cutler, MT Leibowitz, E. Spierings +8 more
2001Cephalalgia100 citations
Semantic Scholar
Amlodipine and Valsartan Combined and as Monotherapy in Stage 2, Elderly, and Black Hypertensive Patients: Subgroup Analyses of 2 Randomized, Placebo‐Controlled Studies
T. Smith, T. Philipp, B. Vaisse, G. Bakris +3 more
2007The Journal of Clinical Hypertension93 citations Open access
Semantic Scholar
Efficacy and Tolerability of Oral Zolmitriptan in Menstrually Associated Migraine: A Randomized, Prospective, Parallel‐Group, Double‐blind, Placebo‐Controlled Study
E. Loder, Stephen D. Silberstein, S. Abu-Shakra, Loretta L. Mueller +1 more
2004Headache81 citations
Semantic Scholar
Pharmacovigilance: reporting requirements throughout a product’s lifecycle
S. Lucas, J. Ailani, T. Smith, Ahmad M. Abdrabboh +2 more
2022Therapeutic Advances in Drug Safety79 citations Open access
Semantic Scholar
Review of duloxetine in the management of diabetic peripheral neuropathic pain
T. Smith, R. Nicholson
2007Vascular Health and Risk Management67 citations
Semantic Scholar
Early Intervention With Almotriptan: Results of the AEGIS Trial (AXERT® Early Migraine Intervention Study)
N. Mathew, G. Finlayson, T. Smith, R. Cady +4 more
2007Headache65 citations Open access
Semantic Scholar
Randomized, controlled trial of lasmiditan over four migraine attacks: Findings from the CENTURION study
M. Ashina, U. Reuter, T. Smith, Judith Krikke-Workel +6 more
2021Cephalalgia61 citations Open access
Semantic Scholar
An open-label 52-week clinical extension comparing duloxetine with routine care in patients with diabetic peripheral neuropathic pain.
J. Wernicke, Fu-Jun Wang, Y. Pritchett, T. Smith +4 more
2007Pain medicine (Malden, Mass.)55 citations
Semantic Scholar
Eptinezumab for the Prevention of Episodic Migraine: Sustained Effect Through 1 Year of Treatment in the PROMISE-1 Study.
T. Smith, M. Janelidze, G. Chakhava, R. Cady +5 more
2020Clinical Therapeutics50 citations Open access
Semantic Scholar
Non-invasive vagus nerve stimulation for prevention of migraine: The multicenter, randomized, double-blind, sham-controlled PREMIUM II trial
Umer Najib, T. Smith, Nada Hindiyeh, J. Saper +7 more
2022Cephalalgia49 citations
Semantic Scholar
Comparative Study of a Combination of Isometheptene Mucate, Dichloralphenazone With Acetaminophen and Sumatriptan Succinate in the Treatment of Migraine
Frederick G. Freitag, Roger Cady, F. Diserio, A. Elkind +7 more
2001Headache49 citations
Semantic Scholar
Needle‐Free Subcutaneous Sumatriptan (Sumavel™ DosePro™): Bioequivalence and Ease of Use
J. Brandes, Roger Cady, F. Freitag, T. Smith +4 more
2009Headache48 citations
Semantic Scholar
Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials
T. Smith, E. Spierings, R. Cady, J. Hirman +8 more
2021The Journal of Headache and Pain44 citations Open access
Semantic Scholar
Low‐Dose Tizanidine With Nonsteroidal Anti‐inflammatory Drugs for Detoxification From Analgesic Rebound Headache
T. Smith
2002Headache42 citations
Semantic Scholar
A Sumatriptan Iontophoretic Transdermal System for the Acute Treatment of Migraine
J. Goldstein, T. Smith, Neil Pugach, J. Griesser +2 more
2012Headache36 citations
Semantic Scholar
Effect of Early Intervention With Almotriptan vs Placebo on Migraine‐Associated Functional Disability: Results From the AEGIS Trial
F. Freitag, T. Smith, N. Mathew, M. Rupnow +5 more
2008Headache34 citations
Semantic Scholar
Sumatriptan/Naproxen Sodium for Migraine: Efficacy, Health Related Quality of Life, and Satisfaction Outcomes
T. Smith, H. Blumenthal, M. Diamond, A. Mauskop +4 more
2007Headache34 citations
Semantic Scholar
Duloxetine in diabetic neuropathy
T. Smith
2006Expert Opinion on Pharmacotherapy34 citations
Semantic Scholar
Evaluation of an oral small‐molecule glucagon‐like peptide‐1 receptor agonist, lotiglipron, for type 2 diabetes and obesity: A dose‐ranging, phase 2, randomized, placebo‐controlled study
Neeta B. Amin, R. Frederich, Nikolaos Tsamandouras, Amina Z. Haggag +9 more
2024Diabetes, obesity and metabolism32 citations
Semantic Scholar
Twelve‐Month Tolerability and Efficacy Study of NP101, the Sumatriptan Iontophoretic Transdermal System
T. Smith, J. Goldstein, R. Singer, Neil Pugach +2 more
2012Headache31 citations
Semantic Scholar
Open‐Label, Long‐Term Tolerability of Naratriptan for Short‐Term Prevention of Menstrually Related Migraine
J. Brandes, T. Smith, M. Diamond, M. Ames
2007Headache31 citations
Semantic Scholar
Medication Class Effects on Visit‐to‐Visit Variability of Blood Pressure Measurements: Analysis of Electronic Health Record Data in the “Real World”
T. Smith, J. Drozda, Jeffrey A. Vanslette, Amanda S. Hoeffken +1 more
2013The Journal of Clinical Hypertension27 citations Open access
Semantic Scholar
STOP 301: A Phase 3, open‐label study of safety, tolerability, and exploratory efficacy of INP104, Precision Olfactory Delivery (POD®) of dihydroergotamine mesylate, over 24/52 weeks in acute treatment of migraine attacks in adult patients
T. Smith, P. Winner, S. Aurora, M. Jeleva +2 more
2021Headache23 citations Open access
Semantic Scholar
Medication overuse headache from antimigraine therapy: clinical features, pathogenesis and management.
T. Smith, J. Stoneman
2004Drugs22 citations
Semantic Scholar
Prevalence of migraine and response to sumatriptan in patients self-reporting tension/stress headache
R. Kaniecki, G. Ruoff, T. Smith, P. Barrett +3 more
2006Current Medical Research and Opinion19 citations
Semantic Scholar
Efficacy and Safety of Carisbamate in Patients with Diabetic Neuropathy or Postherpetic Neuralgia: Results from 3 Randomized, Double‐Blind Placebo‐Controlled Trials
T. Smith, A. Dibernardo, Ying-Qi Shi, M. Todd +2 more
2014Pain Practice16 citations
Semantic Scholar
Addressing the Crisis of Diagnosis and Management of Migraine in Primary Care: A Summary of the American Headache Society Front Line Primary Care Advisory Board
Mia T. Minen, M. Robbins, E. Loder, Stephanie J. Nahas +15 more
2020Headache15 citations Open access
Semantic Scholar
Epidemiology and impact of headache: an overview.
T. Smith
2004Primary Care15 citations
Semantic Scholar
Using artificial intelligence to identify patients with migraine and associated symptoms and conditions within electronic health records
Daniel Riskin, R. Cady, A. Shroff, Nada Hindiyeh +2 more
2023BMC Medical Informatics and Decision Making14 citations Open access
Semantic Scholar
Combination therapy with amlodipine/valsartan in essential hypertension: a 52‐week, randomised, open‐label, extension study
T. Smith, R. Glazer, M. Koren, Margaret Wernsing +1 more
2010International journal of clinical practice13 citations
Semantic Scholar
Cardiovascular outcomes in adults with migraine treated with eptinezumab for migraine prevention: pooled data from four randomized, double-blind, placebo-controlled studies
T. Smith, E. Spierings, R. Cady, J. Hirman +2 more
2021The Journal of Headache and Pain12 citations Open access
Semantic Scholar
Medication Overuse Headache from Antimigraine Therapy
T. Smith, J. Stoneman
2012Drugs12 citations
Semantic Scholar
Views and Perspectives Consensus Statement: Cardiovascular Safety Profile of Triptans (5-HT 1B/1D Agonists) in the Acute Treatment of Migraine
D. Dodick, R. Lipton, V. Martin, V. Papademetriou +9 more
200412 citations
Semantic Scholar
Economic burden and risk factors of migraine disease progression in the US: a retrospective analysis of a commercial payer database
S. Foster, Chi-Chang Chen, Yao Ding, O. Mason +6 more
2020Journal of Medical Economics11 citations Open access
Semantic Scholar
Botulinum neurotoxin type A for treatment of chronic migraine: PREEMPT 2 trial double-blind phase
D. Dodick, T. Smith, W. Becker, A. Gendolla +5 more
200911 citations
Semantic Scholar
Pitfalls in migraine diagnosis and management.
T. Smith
2001Clinical Cornerstone11 citations
Semantic Scholar
Improvement in Function after Lasmiditan Treatment: Post Hoc Analysis of Data from Phase 3 Studies
T. Smith, J. Krege, S. Rathmann, S. Dowsett +4 more
2020Neurological Therapeutics9 citations Open access
Semantic Scholar
Acute Migraine Prescription Patterns Vary by Baseline Cardiovascular Risk and Clinical Characteristics: A Real-World Evidence Study
Li Hu, M. Vincent, Xiang Zhang, E. Dennehy +3 more
2020Pain and Therapy8 citations Open access
Semantic Scholar
Long‐term safety and tolerability of zavegepant 10‐mg nasal spray with concomitant use of anti‐calcitonin gene‐related peptide monoclonal antibodies or other select preventive migraine medications: Results from a phase 2/3 open‐label study
Gary Berman, Kathleen Mullin, T. Smith, Linda Mosher +2 more
2025Headache4 citations
Semantic Scholar
Correction to: Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials
T. Smith, E. Spierings, R. Cady, J. Hirman +8 more
2021The Journal of Headache and Pain3 citations Open access
Semantic Scholar
Eptinezumab Achieved Meaningful Reductions in Migraine Activity Within 24 Hours That Were Sustained Through Week 12: Results From PROMISE-1 (PRevention Of Migraine via Intravenous eptinezumab Safety and Efficacy-1) Phase 3 Trial (P4.092)
T. Smith, D. Biondi, G. Berman, Marshall C. Freeman +2 more
2018Neurology3 citations
Semantic Scholar
The Efficacy of Transdermal Sumatriptan Is Too Low for General Use – a Response
J. Goldstein, T. Smith, Neil Pugach, J. Griesser +2 more
2014Headache3 citations
Semantic Scholar
894: Proton Pump Inhibitors Versus Histamine 2 Receptor Antagonists for Stress Ulcer Prophylaxis
F. Sadaka, S. Trottier, T. Smith, Jeffrey VanSlette +3 more
20133 citations
Semantic Scholar
Corrigendum to "Eptinezumab for the Prevention of Episodic Migraine: Sustained Effect Through 1 Year of Treatment in the PROMISE-1 Study" [Clin Therapeut 42 (12) (2020) 2254-2265].
T. Smith, M. Janelidze, G. Chakhava, R. Cady +5 more
2021Clinical Therapeutics2 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Cady×7
Invite
R. Cady — researcher profile on SciRah
J. Hirman×6
Invite
J. Hirman — researcher profile on SciRah
D. Dodick×4
Invite
D. Dodick — researcher profile on SciRah
V. Martin×4
Invite
V. Martin — researcher profile on SciRah

×4

Invite

B. Schaeffler — researcher profile on SciRah

J. Goldstein×4

Invite

J. Goldstein — researcher profile on SciRah

S. Silberstein×3

Invite

S. Silberstein — researcher profile on SciRah

Invite

R. Glazer — researcher profile on SciRah

E. Spierings×3

Invite

E. Spierings — researcher profile on SciRah

Vivienne Shen×3

Invite

Vivienne Shen — researcher profile on SciRah

Invite

Neil Pugach — researcher profile on SciRah

Invite

M. Pierce — researcher profile on SciRah